|
C6ORF167 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.176200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.793800E-01 |
| Normal-vs-Stage2 |
5.496200E-01 |
| Normal-vs-Stage3 |
2.137400E-01 |
| Normal-vs-Stage4 |
5.785800E-01 |
| Stage1-vs-Stage2 |
1.917770E-01 |
| Stage1-vs-Stage3 |
1.000000E-02 |
| Stage1-vs-Stage4 |
1.997810E-01 |
| Stage2-vs-Stage3 |
5.652800E-01 |
| Stage2-vs-Stage4 |
9.286800E-01 |
| Stage3-vs-Stage4 |
6.860800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.637000E-01 |
| Normal-vs-AfricanAmerican |
9.419200E-01 |
| Normal-vs-Asian |
8.499200E-01 |
| Caucasian-vs-AfricanAmerican |
9.419200E-01 |
| Caucasian-vs-Asian |
5.163600E-01 |
| AfricanAmerican-vs-Asian |
5.963000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.936400E-01 |
| Normal-vs-Female |
2.944200E-01 |
| Male-vs-Female |
2.020900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.278000E-01 |
| Normal-vs-Extreme_Weight |
5.435200E-01 |
| Normal-vs-Obese |
5.707400E-01 |
| Normal-vs-Extreme_Obese |
6.498000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.096200E-01 |
| Normal_Weight-vs-Obese |
1.970600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.008400E-01 |
| Extreme_Weight-vs-Obese |
8.300100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.483400E-01 |
| Obese-vs-Extreme_Obese |
9.303500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.043000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.418200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.420000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.209600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.092630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.804100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.591900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.784340E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.914300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.048600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.374600E-01 |
| Normal-VS-Type2 PRCC |
7.410200E-01 |
| Normal-VS-KIRP CIMP |
2.399800E-03 |
| Normal-VS-Unclassified PRCC |
6.570600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.625800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.719100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.514010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.275200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.019850E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.317500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.703400E-01 |
| Normal-vs-N1 |
5.986200E-02 |
| Normal-vs-N2 |
7.276000E-01 |
| N0-vs-N1 |
1.804150E-02 |
| N0-vs-N2 |
7.883600E-01 |
| N1-vs-N2 |
9.199500E-03 |
|
|
